NewslettersProstate Cell News Randomized Phase II Trial of Nivolumab and Ipilimumab with or without Stereotactic Body Radiation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: The CheckPRO, CA209-8TY Trial By Jamie Kang - July 24, 2026 0 5 Scientists hypothesized that the addition of stereotactic body radiation therapy could enhance immune responses and improve treatment outcomes. [Journal for Immunotherapy of Cancer] Full Article